Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular and erythrocyte non-protein and protein thiols represent a collective pool of sulfur-containing compounds that serve as the primary defense mechanism against oxidative stress and electrophilic insult. The non-protein thiol (NPSH) fraction is predominantly composed of reduced glutathione (GSH), while the protein thiol (PSH) fraction consists of cysteine residues on various proteins, such as hemoglobin in erythrocytes and albumin in plasma. These thiols maintain the intracellular redox environment by scavenging reactive oxygen species (ROS) and facilitating the detoxification of xenobiotics through conjugation reactions. In clinical pharmacology, this thiol pool is rarely a direct therapeutic target but is frequently monitored as a biomarker of oxidative stress and drug-induced toxicity. For instance, the depletion of erythrocyte and hepatic glutathione is a hallmark of acetaminophen overdose, where the reactive metabolite NAPQI exhausts the thiol supply, leading to cell death. Conversely, drugs like N-acetylcysteine are administered to replenish these thiol stores. Because this term describes a broad chemical class and a physiological compartment rather than a specific protein or receptor, it is classified as an aggregate biomarker or a metabolic pool rather than a discrete molecular target.
Drugs typically interact with this pool by either replenishing it (e.g., N-acetylcysteine providing cysteine for glutathione synthesis), depleting it through reactive metabolite conjugation (e.g., NAPQI from acetaminophen), or utilizing thiol groups for metal chelation and ROS scavenging.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and erythrocyte non-protein and protein thiols (NPSH and PSH).